{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:29:28Z","timestamp":1792690168932,"version":"4.5.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T00:00:00Z","timestamp":1692403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T00:00:00Z","timestamp":1692403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Vestre Viken Hospital Trust"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Personality disorders (PDs) are associated with high levels of societal costs, regardless of whether a single PD or a broad range of PDs have been studied. However, research on the relative contribution of specific PD-types on societal costs is limited. The aim of this study was to explore the possible contributions of the individual DSM-5 categories of PDs on the level of societal costs and its components (health service costs and productivity loss), while controlling for the impact of comorbid mental health and substance use disorders on these outcomes. Participants (<jats:italic>n<\/jats:italic>\u2009=\u2009798) were retrieved from the quality register of the Norwegian Network for Personality Disorders\u2014a collaboration of PD-treatment units within specialist mental health services. The patients were referred to treatment in the time-period 2017\u20132020. Costs were assessed using a structured interview covering the 6-month period prior to assessment. Diagnoses were determined by semi-structured diagnostic interviews (SCID-5-PD and M.I.N.I.). Statistics included multiple regression analyses. The main result was that no specific PD had a unique contribution to the high level of\u00a0societal costs\u00a0generally found among treatment-seeking patients with PDs. Borderline PD (BPD) was the only PD with significantly higher health service costs than the other PDs, while BPD, avoidant PD, and unspecified PD were independently associated with enhanced productivity loss. The differential cost-effects of specific PDs on the cost components\u00a0were small. Several comorbid mental health and substance use disorders were significant contributors to costs, irrespective of PD status. The results underscore the importance of developing and implementing effective treatments for a broader range of PDs, to reduce the high levels of societal costs associated with all PDs.<\/jats:p>","DOI":"10.1007\/s00406-023-01655-1","type":"journal-article","created":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T20:19:39Z","timestamp":1692476379000},"page":"139-149","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Societal costs of personality disorders among treatment-seeking patients in Norway: the relative contribution of specific DSM-5 categories"],"prefix":"10.1007","volume":"274","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2999-7679","authenticated-orcid":false,"given":"C. A.","family":"Sveen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. A.","family":"Ulvestad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. E.","family":"Zahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Wilberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. H.","family":"Kvarstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,19]]},"reference":[{"key":"1655_CR1","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1002\/jclp.23504","volume":"79","author":"CA Sveen","year":"2023","unstructured":"Sveen CA et al (2023) Societal costs of personality disorders\u2014a cross-sectional multicenter study of treatment-seeking patients in mental health services in Norway (submitted, under review). Network for personality disorder, section for personality psychiatry and specialized treatments, department for national and regional functions, division of mental health and addiction, Oslo university hospital, Norway. J Clin Psychol 79:1752","journal-title":"J Clin Psychol"},{"issue":"2","key":"1655_CR2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.4088\/JCP.v69n0212","volume":"69","author":"DI Soeteman","year":"2008","unstructured":"Soeteman DI et al (2008) The economic burden of personality disorders in mental health care. J Clin Psychiatry 69(2):259\u2013265","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"1655_CR3","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.eurpsy.2014.07.001","volume":"29","author":"L Salvador-Carulla","year":"2014","unstructured":"Salvador-Carulla L et al (2014) Cost of borderline personality disorder in Catalonia (Spain). Eur Psychiatry 29(8):490\u2013497","journal-title":"Eur Psychiatry"},{"issue":"5","key":"1655_CR4","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/acps.13094","volume":"140","author":"LH Hastrup","year":"2019","unstructured":"Hastrup LH et al (2019) Societal costs of borderline personality disorders: a matched-controlled nationwide study of patients and spouses. Acta Psychiatr Scand 140(5):458\u2013467","journal-title":"Acta Psychiatr Scand"},{"issue":"6","key":"1655_CR5","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.eurpsy.2007.04.001","volume":"22","author":"AD van Asselt","year":"2007","unstructured":"van Asselt AD et al (2007) The cost of borderline personality disorder: societal cost of illness in BPD-patients. Eur Psychiatry 22(6):354\u2013361","journal-title":"Eur Psychiatry"},{"key":"1655_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.brat.2014.07.004","volume":"61","author":"T Wagner","year":"2014","unstructured":"Wagner T et al (2014) Societal cost-of-illness in patients with borderline personality disorder one year before, during and after dialectical behavior therapy in routine outpatient care. Behav Res Ther 61:12\u201322","journal-title":"Behav Res Ther"},{"issue":"1","key":"1655_CR7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/acps.13292","volume":"144","author":"LH Hastrup","year":"2021","unstructured":"Hastrup LH et al (2021) Costs of schizotypal disorder: a matched-controlled nationwide register-based study of patients and spouses. Acta Psychiatr Scand 144(1):60\u201371","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"1655_CR8","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s00406-021-01332-1","volume":"272","author":"T Wagner","year":"2022","unstructured":"Wagner T et al (2022) The societal cost of treatment-seeking patients with borderline personality disorder in Germany. Eur Archiv Psychiatry Clin Neurosci 272(4):741","journal-title":"Eur Archiv Psychiatry Clin Neurosci"},{"key":"1655_CR9","unstructured":"APA, Diagnostic and Statistical Manual of Mental Disorders 5th ed, ed. A.P. Association. 2013, Washington: American Psychiatric Publishing."},{"issue":"6","key":"1655_CR10","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/sjop.12076","volume":"54","author":"MS Johansen","year":"2013","unstructured":"Johansen MS et al (2013) Emotional dysfunction in avoidant compared to borderline personality disorder: a study of affect consciousness. Scand J Psychol 54(6):515\u2013521","journal-title":"Scand J Psychol"},{"issue":"4","key":"1655_CR11","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/pmh.1226","volume":"7","author":"EH Kvarstein","year":"2013","unstructured":"Kvarstein EH, Karterud S (2013) Large variation of severity and longitudinal change of symptom distress among patients with personality disorders. Personal Ment Health 7(4):265\u2013276","journal-title":"Personal Ment Health"},{"issue":"4","key":"1655_CR12","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1521\/pedi.2012.26.4.593","volume":"26","author":"DJ Feenstra","year":"2012","unstructured":"Feenstra DJ et al (2012) The burden of disease among adolescents with personality pathology: quality of life and costs. J Pers Disord 26(4):593\u2013604","journal-title":"J Pers Disord"},{"issue":"3","key":"1655_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1521\/pedi.17.3.243.22151","volume":"17","author":"S Karterud","year":"2003","unstructured":"Karterud S et al (2003) Day treatment of patients with personality disorders: experiences from a Norwegian treatment research network. J Pers Disord 17(3):243\u2013262","journal-title":"J Pers Disord"},{"key":"1655_CR14","first-page":"1","volume":"77","author":"G Pedersen","year":"2022","unstructured":"Pedersen G et al (2022) The Norwegian network for personality disorders\u2014development, contributions and challenges through 30 years. Nord J Psychiatry 77:1\u20139","journal-title":"Nord J Psychiatry"},{"key":"1655_CR15","volume-title":"User\u2019s guide for the SCID-5-PD (structured clinical interview for DSM-5 personality disorder)","author":"MB First","year":"2016","unstructured":"First MB et al (2016) User\u2019s guide for the SCID-5-PD (structured clinical interview for DSM-5 personality disorder). American Psychiatric Association, Arlington"},{"key":"1655_CR16","unstructured":"Sheehan DV, Lecrubier Y, Janavs J, Knapp E, Weiller E, Bonora LI, Mini International Neuropsychiatric Interview (MINI). 1994: Tampa, Florida and Paris, France: University of South Florida Institute for Research in Psychiatry and INSERM-H\u00f4pital de la Salp\u00e9tri\u00e8re."},{"key":"1655_CR17","first-page":"22","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan DV et al (1998) The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59:22\u201323","journal-title":"J Clin Psychiatry"},{"key":"1655_CR18","unstructured":"APA, Diagnostic and Statistical Manual of Mental Disorders. 3rd ed, ed. A.P. Association. 1980, Washington: American Psychiatric Publishing."},{"issue":"6","key":"1655_CR19","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1521\/pedi.2005.19.6.674","volume":"19","author":"JL Pagan","year":"2005","unstructured":"Pagan JL et al (2005) Personality disorder not otherwise specified: Searching for an empirically based diagnostic threshold. J Personal Disord 19(6):674","journal-title":"J Personal Disord"},{"issue":"5","key":"1655_CR20","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.comppsych.2007.12.008","volume":"49","author":"T Wilberg","year":"2008","unstructured":"Wilberg T et al (2008) A study of patients with personality disorder not otherwise specified. Compr Psychiatry 49(5):460","journal-title":"Compr Psychiatry"},{"issue":"4","key":"1655_CR21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/pmh.1234","volume":"7","author":"G Pedersen","year":"2013","unstructured":"Pedersen G et al (2013) The impact of extended longitudinal observation on the assessment of personality disorders. Personal Mental Health 7(4):277","journal-title":"Personal Mental Health"},{"issue":"7","key":"1655_CR22","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.comppsych.2012.03.007","volume":"53","author":"EF Coccaro","year":"2012","unstructured":"Coccaro EF, Nayyer H, McCloskey MS (2012) Personality disorder-not otherwise specified evidence of validity and consideration for DSM-5. Compr Psychiatry 53(7):907","journal-title":"Compr Psychiatry"},{"issue":"4","key":"1655_CR23","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1521\/pedi.2007.21.4.359","volume":"21","author":"R Verheul","year":"2007","unstructured":"Verheul R, Bartak A, Widiger T (2007) Prevalence and construct validity of personality disorder not otherwise specified (PDNOS). J Personal Disord 21(4):359","journal-title":"J Personal Disord"},{"issue":"4","key":"1655_CR24","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1521\/pedi.2004.18.4.309","volume":"18","author":"R Verheul","year":"2004","unstructured":"Verheul R, Widiger TA (2004) A meta-analysis of the prevalence and usage of the personality disorder not otherwise specified (PDNOS) diagnosis. J Pers Disord 18(4):309\u2013319","journal-title":"J Pers Disord"},{"issue":"5","key":"1655_CR25","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/0010-440X(83)90032-9","volume":"24","author":"RL Spitzer","year":"1983","unstructured":"Spitzer RL (1983) Psychiatric diagnosis: are clinicians still necessary? Compr Psychiatry 24(5):399\u2013411","journal-title":"Compr Psychiatry"},{"issue":"4","key":"1655_CR26","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1080\/10503307.2012.662608","volume":"22","author":"FS Gullestad","year":"2012","unstructured":"Gullestad FS et al (2012) Is treatment in a day hospital step-down program superior to outpatient individual psychotherapy for patients with personality disorders? 36 months follow-up of a randomized clinical trial comparing different treatment modalities. Psychother Res 22(4):426\u2013441","journal-title":"Psychother Res"},{"issue":"4","key":"1655_CR27","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3350\/cmh.2014.20.4.327","volume":"20","author":"C Jo","year":"2014","unstructured":"Jo C (2014) Cost-of-illness studies: concepts, scopes, and methods. Clin Mol Hepatol 20(4):327\u2013337","journal-title":"Clin Mol Hepatol"},{"key":"1655_CR28","unstructured":"IPSOS. Variasjoner i finansiering av fastlegeordningen. 2018; https:\/\/www.ks.no\/contentassets\/11090ac4bb2445c88e049c469f13b7e6\/rapport---variasjoner-i-finansiering-av-fastlegeordningen_310518.pdf."},{"key":"1655_CR29","unstructured":"SSB. Consumer Price Index. 2018a; https:\/\/www.ssb.no\/kpi."},{"key":"1655_CR30","unstructured":"SSB. Table 10141: Consultations by GPs 2018. 2018b; https:\/\/www.ssb.no\/statbank\/table\/10141\/."},{"key":"1655_CR31","unstructured":"MentalHelse. Hjelpetelefonen \u00c5rsrapport 2018. 2019; https:\/\/mentalhelse.no\/attachments\/341cd4223bcaf4155970e5c76629daf45ae17c93\/353-20190405073800383973.pdf."},{"key":"1655_CR32","unstructured":"Osloakutten. Priser. 2018; https:\/\/www.osloakutten.no\/priser\/."},{"key":"1655_CR33","unstructured":"Helsedirektoratet, Innsatsstyrt finansiering (ISF) - regelverk. 2018a."},{"key":"1655_CR34","unstructured":"Helsedirektoratet. Samdata, Produktivitet innen psykisk helsevern og tverrrfaglig spesialisert rusbehandling (PHR). 2018b; https:\/\/statistikk.helsedirektoratet.no\/bi\/Dashboard\/84179fbd-a358-4030-800d-2d6c61ad7836?e=false&vo=viewonly."},{"key":"1655_CR35","unstructured":"Helsedirektoratet, Helsedirektoratet, Samdata, Spesialisthelsetjenesten, Produktivitet i somatikken, Kostnadsindikatorer, Figur 1 kostnadsniv\u00e5, valg av indikator: kostnad pr ligged\u00f8gn. 2018c."},{"key":"1655_CR36","unstructured":"Legemiddelverket. n.d. Norwegian Medicines Agency. https:\/\/legemiddelverket.no\/."},{"issue":"6","key":"1655_CR37","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s40258-018-0416-4","volume":"16","author":"J Pike","year":"2018","unstructured":"Pike J, Grosse SD (2018) Friction cost estimates of productivity costs in cost-of-illness studies in comparison with human capital estimates: a review. Appl Health Econ Health Policy 16(6):765\u2013778","journal-title":"Appl Health Econ Health Policy"},{"issue":"Suppl 1","key":"1655_CR38","doi-asserted-by":"publisher","first-page":"i89","DOI":"10.1136\/ard.2009.117150","volume":"69","author":"WB van den Hout","year":"2010","unstructured":"van den Hout WB (2010) The value of productivity: human-capital versus friction-cost method. Ann Rheum Dis 69(Suppl 1):i89-91","journal-title":"Ann Rheum Dis"},{"key":"1655_CR39","unstructured":"NAV, Utbetalinger til personer i Norge per fylke og kommune 2018."},{"key":"1655_CR40","unstructured":"SSB. Average monthly payment. 2018d; https:\/\/www.ssb.no\/arbeid-og-lonn\/statistikker\/lonnansatt."},{"issue":"2","key":"1655_CR41","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0022-3999(98)00118-4","volume":"47","author":"D Gill","year":"1999","unstructured":"Gill D, Sharpe M (1999) Frequent consulters in general practice: a systematic review of studies of prevalence, associations and outcome. J Psychosom Res 47(2):115\u2013130","journal-title":"J Psychosom Res"},{"issue":"4","key":"1655_CR42","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0895-4356(00)00314-0","volume":"54","author":"R Bender","year":"2001","unstructured":"Bender R, Lange S (2001) Adjusting for multiple testing\u2013when and how? J Clin Epidemiol 54(4):343\u2013349","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"1655_CR43","first-page":"9","volume":"22","author":"PJO Wong","year":"2017","unstructured":"Wong PJO, Wong ACM (2017) Data transformations for inference with linear regression: Clarifications and recommendations. Pract Assessment Res Evaluat 22(1):9","journal-title":"Pract Assessment Res Evaluat"},{"key":"1655_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fpsyg.2018.02104","volume":"9","author":"J Pek","year":"2018","unstructured":"Pek J, Wong O, Wong ACM (2018) How to address non-normality: A taxonomy of approaches, reviewed, and illustrated. Front Psychol 9:17","journal-title":"Front Psychol"},{"key":"1655_CR45","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jclinepi.2017.12.006","volume":"98","author":"AF Schmidt","year":"2018","unstructured":"Schmidt AF, Finan C (2018) Linear regression and the normality assumption. J Clin Epidemiol 98:146\u2013151","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"1655_CR46","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1037\/per0000422","volume":"12","author":"A Bateman","year":"2021","unstructured":"Bateman A et al (2021) Eight-year prospective follow-up of mentalization-based treatment versus structured clinical management for people with borderline personality disorder. Personal Disord 12(4):291\u2013299","journal-title":"Personal Disord"},{"issue":"12","key":"1655_CR47","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1176\/appi.ajp.2009.09040539","volume":"166","author":"A Bateman","year":"2009","unstructured":"Bateman A, Fonagy P (2009) Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder. Am J Psychiatry 166(12):1355\u20131364","journal-title":"Am J Psychiatry"},{"issue":"12","key":"1655_CR48","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1176\/appi.ajp.2009.09010039","volume":"166","author":"SF McMain","year":"2009","unstructured":"McMain SF et al (2009) A randomized trial of dialectical behavior therapy versus general psychiatric management for borderline personality disorder. Am J Psychiatry 166(12):1365\u20131374","journal-title":"Am J Psychiatry"},{"key":"1655_CR49","first-page":"CD012955","volume":"5","author":"OJ Storebo","year":"2020","unstructured":"Storebo OJ et al (2020) Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev 5:CD012955","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"1655_CR50","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1176\/appi.ajp.158.2.295","volume":"158","author":"DS Bender","year":"2001","unstructured":"Bender DS et al (2001) Treatment utilization by patients with personality disorders. Am J Psychiatry 158(2):295\u2013302","journal-title":"Am J Psychiatry"},{"key":"1655_CR51","first-page":"CD007668","volume":"9","author":"S Gibbon","year":"2020","unstructured":"Gibbon S et al (2020) Psychological interventions for antisocial personality disorder. Cochrane Database Syst Rev 9:CD007668","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"1655_CR52","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11920-016-0665-6","volume":"18","author":"A Weinbrecht","year":"2016","unstructured":"Weinbrecht A et al (2016) Avoidant personality disorder: a current review. Curr Psychiatry Rep 18(3):29","journal-title":"Curr Psychiatry Rep"},{"issue":"Suppl","key":"1655_CR53","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1521\/pedi.2020.34.supp.177","volume":"34","author":"RP Drozek","year":"2020","unstructured":"Drozek RP, Unruh BT (2020) Mentalization-based treatment for pathological narcissism. J Pers Disord 34(Suppl):177\u2013203","journal-title":"J Pers Disord"},{"issue":"1","key":"1655_CR54","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/YCO.0000000000000211","volume":"29","author":"L Lampe","year":"2016","unstructured":"Lampe L (2016) Avoidant personality disorder as a social anxiety phenotype: Risk factors, associations and treatment. Curr Opin Psychiatry 29(1):64","journal-title":"Curr Opin Psychiatry"},{"issue":"3","key":"1655_CR55","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/NMD.0000000000001432","volume":"210","author":"S Simonsen","year":"2022","unstructured":"Simonsen S et al (2022) Treating avoidant personality disorder with combined individual metacognitive interpersonal therapy and group mentalization-based treatment: a pilot study. J Nerv Ment Dis 210(3):163\u2013171","journal-title":"J Nerv Ment Dis"},{"issue":"4","key":"1655_CR56","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11920-019-1012-5","volume":"21","author":"J Volkert","year":"2019","unstructured":"Volkert J, Hauschild S, Taubner S (2019) Mentalization-based treatment for personality disorders: efficacy, effectiveness, and new developments. Curr Psychiatry Rep 21(4):25","journal-title":"Curr Psychiatry Rep"},{"issue":"3","key":"1655_CR57","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1159\/000304176","volume":"43","author":"C Bock","year":"2010","unstructured":"Bock C et al (2010) The influence of comorbid personality disorder and neuroticism on treatment outcome in first episode depression. Psychopathology 43(3):197\u2013204","journal-title":"Psychopathology"},{"issue":"2","key":"1655_CR58","doi-asserted-by":"publisher","first-page":"196","DOI":"10.4088\/JCP.v69n0205","volume":"69","author":"KM Holma","year":"2008","unstructured":"Holma KM et al (2008) Long-term outcome of major depressive disorder in psychiatric patients is variable. J Clin Psychiatry 69(2):196\u2013205","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"1655_CR59","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1176\/appi.ajp.2009.09071023","volume":"167","author":"LC Morey","year":"2010","unstructured":"Morey LC et al (2010) State effects of major depression on the assessment of personality and personality disorder. Am J Psychiatry 167(5):528\u2013535","journal-title":"Am J Psychiatry"},{"issue":"1","key":"1655_CR60","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1521\/pedi.2010.24.1.83","volume":"24","author":"AE Skodol","year":"2010","unstructured":"Skodol AE et al (2010) Personality disorders and mood disorders: perspectives on diagnosis and classification from studies of longitudinal course and familial associations. J Pers Disord 24(1):83\u2013108","journal-title":"J Pers Disord"},{"issue":"4","key":"1655_CR61","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1034\/j.1600-0447.2000.102004256.x","volume":"102","author":"TH McGlashan","year":"2000","unstructured":"McGlashan TH et al (2000) The Collaborative longitudinal personality disorders study: baseline axis I\/II and II\/II diagnostic co-occurrence. Acta Psychiatr Scand 102(4):256\u2013264","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"1655_CR62","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1176\/ajp.152.4.571","volume":"152","author":"JM Oldham","year":"1995","unstructured":"Oldham JM et al (1995) Comorbidity of axis I and axis II disorders. Am J Psychiatry 152(4):571\u2013578","journal-title":"Am J Psychiatry"},{"issue":"4","key":"1655_CR63","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.psc.2018.07.009","volume":"41","author":"R Shah","year":"2018","unstructured":"Shah R, Zanarini MC (2018) Comorbidity of borderline personality disorder: current status and future directions. Psychiatr Clin North Am 41(4):583\u2013593","journal-title":"Psychiatr Clin North Am"},{"issue":"2","key":"1655_CR64","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1053\/comp.2001.19749","volume":"42","author":"MC Zanarini","year":"2001","unstructured":"Zanarini MC et al (2001) Treatment histories of borderline inpatients. Compr Psychiatry 42(2):144","journal-title":"Compr Psychiatry"},{"issue":"3","key":"1655_CR65","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1017\/S003329170400354X","volume":"35","author":"AE Skodol","year":"2005","unstructured":"Skodol AE et al (2005) Stability of functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder over two years. Psychol Med 35(3):443","journal-title":"Psychol Med"},{"issue":"4","key":"1655_CR66","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1521\/pedi.2009.23.4.346","volume":"23","author":"MC Zanarini","year":"2009","unstructured":"Zanarini MC et al (2009) The 10-year course of social security disability income reported by patients with borderline personality disorder and axis II comparison subjects. J Pers Disord 23(4):346\u2013356","journal-title":"J Pers Disord"},{"issue":"5","key":"1655_CR67","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1521\/pedi.2005.19.5.466","volume":"19","author":"P Cohen","year":"2005","unstructured":"Cohen P et al (2005) The children in the community study of developmental course of personality disorder. J Pers Disord 19(5):466\u2013486","journal-title":"J Pers Disord"},{"issue":"4","key":"1655_CR68","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1034\/j.1600-0447.2000.102004265.x","volume":"102","author":"JG Johnson","year":"2000","unstructured":"Johnson JG et al (2000) Age-related change in personality disorder trait levels between early adolescence and adulthood: a community-based longitudinal investigation. Acta Psychiatr Scand 102(4):265\u2013275","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"1655_CR69","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1521\/pedi.2007.21.5.552","volume":"21","author":"V Cramer","year":"2007","unstructured":"Cramer V, Torgersen S, Kringlen E (2007) Socio-demographic conditions, subjective somatic health, axis I disorders and personality disorders in the common population: The relationship to quality of life. J Personal Disord 21(5):552","journal-title":"J Personal Disord"},{"issue":"6","key":"1655_CR70","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1037\/per0000471","volume":"12","author":"EH Kvarstein","year":"2021","unstructured":"Kvarstein EH et al (2021) Avoidant personality disorder and social functioning: a longitudinal, observational study investigating predictors of change in a clinical sample. Personal Disord Theory Res Treat 12(6):594","journal-title":"Personal Disord Theory Res Treat"},{"issue":"6","key":"1655_CR71","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.comppsych.2011.10.007","volume":"53","author":"I Olsson","year":"2012","unstructured":"Olsson I, Dahl AA (2012) Avoidant personality problems-their association with somatic and mental health, lifestyle, and social network a community-based study. Compr Psychiatry 53(6):813","journal-title":"Compr Psychiatry"},{"issue":"5","key":"1655_CR72","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1080\/08039480902831322","volume":"63","author":"T Wilberg","year":"2009","unstructured":"Wilberg T et al (2009) The impact of avoidant personality disorder on psychosocial impairment is substantial. Nordic J Psychiatry 63(5):390","journal-title":"Nordic J Psychiatry"},{"issue":"5","key":"1655_CR73","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/eat.23486","volume":"54","author":"J Streatfeild","year":"2021","unstructured":"Streatfeild J et al (2021) Social and economic cost of eating disorders in the United States: evidence to inform policy action. Int J Eating Disord 54(5):851","journal-title":"Int J Eating Disord"},{"issue":"3","key":"1655_CR74","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1521\/pedi.2008.22.3.259","volume":"22","author":"DI Soeteman","year":"2008","unstructured":"Soeteman DI, Verheul R, Busschbach JJ (2008) The burden of disease in personality disorders: diagnosis-specific quality of life. J Pers Disord 22(3):259\u2013268","journal-title":"J Pers Disord"},{"issue":"3","key":"1655_CR75","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jcrimjus.2015.04.009","volume":"43","author":"N Wickramasekera","year":"2015","unstructured":"Wickramasekera N et al (2015) Cost of crime: a systematic review. J Crim Justice 43(3):218","journal-title":"J Crim Justice"},{"key":"1655_CR76","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1037\/per0000575","volume":"14","author":"DT Gatner","year":"2022","unstructured":"Gatner DT et al (2022) How much does that cost? Examining the economic costs of crime in North America attributable to people with psychopathic personality disorder. Personal Disord Theory Res Treat 14:391","journal-title":"Personal Disord Theory Res Treat"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-023-01655-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00406-023-01655-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-023-01655-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T07:05:14Z","timestamp":1705043114000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00406-023-01655-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,19]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1655"],"URL":"https:\/\/doi.org\/10.1007\/s00406-023-01655-1","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,19]]},"assertion":[{"value":"9 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Se the Ethics section in the main text. The standard text suggested at the journal\u2019s webpage was not applicable, because the data were anonymous, hence formal approval from the Norwegian State Data Inspectorate and Regional Committee for Medical Research and Ethics was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable because the data are anonymous. See also the Ethics section of the main text.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patients consent statement"}}]}}